Skip to content

Influence of Rapydan on Clinical Chemistry and Hematology Measurements

Does Rapydan Influence Routine Clinical Chemistry and Hematology Measurements?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00765934
Enrollment
25
Registered
2008-10-03
Start date
2009-11-30
Completion date
2010-05-31
Last updated
2010-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Healthy

Brief summary

There is an increasing awareness of the importance of treating procedure-related pain. Patients undergoing vascular access procedures are often afraid of needles and the discomfort associated with injections. This type of pain and/or fear can be stressful to patients. \[1\] For prevention of the pain associated with these procedures, the hospital is using Rapydan plasters. Rapydan consists out of two local anesthetics: lidocaine and tetracaïne. Rapydan produces topical anesthesia after an application time of 30 minutes and is used in the Martini Hospital for pain relieve by venipuncture and IV cannulation. The venous blood draining the anaesthetized skin contains a higher blood concentration of the local anesthetics than does venous blood in other parts of the body \[2\] Although the concentrations of the local anesthetics are low in patients with normal skin, the question is whether the presence of the local anesthetics which Rapydan contains might influence routine measurements in clinical chemistry and hematology.

Interventions

lidocaine / tetracaine 70/70 mg patch

Sponsors

LabNoord
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

Volunteers 20-60 years who are decision making competent

Exclusion criteria

Patients with local anesthetic allergy Patients using antiarrhythmic drugs Patients using other local anesthetics

Design outcomes

Primary

MeasureTime frame
Routine Clinical Chemistry measurements differences1

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026